Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure; loprazolam (INN), mecloqualone (INN), methaqualone (INN), and zipeprol (INN); salts thereof

HS v2017 Code: 293355

About heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure; loprazolam (inn), mecloqualone (inn), methaqualone (inn), and zipeprol (inn); salts thereof

HS code 293355 covers a range of heterocyclic compounds that contain a pyrimidine or piperazine ring structure. These compounds are widely used in the pharmaceutical industry, particularly in the production of various drugs and medications. The importance of this industry lies in its ability to provide essential building blocks for the development of new and innovative therapeutic solutions, contributing to advancements in healthcare and the overall well-being of the global population.

Production process

The production of the compounds covered under HS code 293355 typically involves a series of chemical synthesis steps. This may include the cyclization of appropriate precursors, the introduction of specific functional groups, and the purification of the final products. The precise techniques employed can vary depending on the specific compound being manufactured, but generally involve well-established organic chemistry methods and processes.

Production inputs

The main inputs required for the production of the compounds under HS code 293355 include various organic chemicals, such as 290100 Acyclic hydrocarbons, 290200 Cyclic hydrocarbons, and 290300 Halogenated derivatives of hydrocarbons. Additionally, specialized equipment and machinery, such as chemical reactors, distillation columns, and purification systems, are essential for the efficient and high-quality production of these heterocyclic compounds.

Production outputs

The compounds covered under HS code 293355 are primarily used as intermediates in the pharmaceutical industry, where they serve as building blocks for the synthesis of various drugs and medications. These heterocyclic compounds may be further processed and incorporated into final drug products that fall under other HS codes, such as 300210 Antisera and other blood fractions and modified immunological products, 300220 Vaccines for human medicine, and 300290 (Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; toxins, cultures of micro-organisms (excluding yeasts) and similar products). The versatility of these compounds makes them valuable in the development of a wide range of pharmaceutical and therapeutic solutions.

Revisions to 293355

Classification codes are adjusted frequently. The code may have been revised or replaced between system versions. The table below shows the history (newest to oldest) of the code 293355. The most recent 1 version of this code (293355) is in the HS v2022 system:

This page shows a legacy version of code 293355 ( HS v2017).

Family tree for heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure; loprazolam (inn), mecloqualone (inn), methaqualone (inn), and zipeprol (inn); salts thereof

    graph LR
    A["<a href='/classifications/hs/v2017/29'>29: Organic chemicals</a>"]
A --> B["<a href='/classifications/hs/v2017/2933'>2933: Heterocyclic compounds with nitrogen hetero-atom(s) only</a>"]
B --> C["<a href='/classifications/hs/v2017/293355'>293355: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure; loprazolam (INN), mecloqualone (INN), methaqualone (INN), and zipeprol (INN); salts thereof</a>"]

    B --> D["<a href='/classifications/hs/v2017/293311'>293311: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, phenazone (antipyrin) and its derivatives</a>"]
B --> E["<a href='/classifications/hs/v2017/293319'>293319: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives</a>"]
B --> F["<a href='/classifications/hs/v2017/293321'>293321: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, hydantoin and its derivatives</a>"]
B --> G["<a href='/classifications/hs/v2017/293329'>293329: Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives</a>"]
B --> H["<a href='/classifications/hs/v2017/293331'>293331: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, pyridine and its salts</a>"]
B --> I["<a href='/classifications/hs/v2017/293332'>293332: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, piperidine and its salts</a>"]
B --> J["<a href='/classifications/hs/v2017/293333'>293333: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts</a>"]
B --> K["<a href='/classifications/hs/v2017/293339'>293339: Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, n.e.c. in 2933.3</a>"]
B --> L["<a href='/classifications/hs/v2017/293341'>293341: Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, levorphanol (INN) and its salts</a>"]
B --> M["<a href='/classifications/hs/v2017/293349'>293349: Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts</a>"]
B --> N["<a href='/classifications/hs/v2017/293352'>293352: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its salts</a>"]
B --> O["<a href='/classifications/hs/v2017/293353'>293353: Allobarbital (INN), amobarbital (INN), barbital (INN), butalbital (INN), butobarbital, cyclobarbital (INN), methylphenobarbital (INN), pentobarbital (INN), phenobarbital (INN), secbutabarbital (INN), secobarbital (INN) and vinylbital (INN); salts thereof</a>"]
B --> P["<a href='/classifications/hs/v2017/293354'>293354: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, other derivatives of malonylurea (barbituric acid) and salts thereof, n.e.c. in 2933.53</a>"]
B --> Q["<a href='/classifications/hs/v2017/293359'>293359: Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5</a>"]
B --> R["<a href='/classifications/hs/v2017/293361'>293361: Heterocyclic compounds; containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamine</a>"]
B --> S["<a href='/classifications/hs/v2017/293369'>293369: Heterocyclic compounds; containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine</a>"]
B --> T["<a href='/classifications/hs/v2017/293371'>293371: Heterocyclic compounds; lactams; 6-hexanelactam (epsilon-caprolactam)</a>"]
B --> U["<a href='/classifications/hs/v2017/293372'>293372: Heterocyclic compounds; lactams; clobazam (INN) and methyprylon (INN)</a>"]
B --> V["<a href='/classifications/hs/v2017/293379'>293379: Heterocyclic compounds; lactams; other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN)</a>"]
B --> W["<a href='/classifications/hs/v2017/293391'>293391: Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)</a>"]
B --> X["<a href='/classifications/hs/v2017/293392'>293392: Heterocyclic compounds; azinphos-methyl (ISO)</a>"]
B --> Y["<a href='/classifications/hs/v2017/293399'>293399: Heterocyclic compounds; n.e.c. in headings no. 2933</a>"]

    

    %% Color coordination by level

    classDef level1 color:#000,fill:#a8f9ff,stroke:#333,stroke-width:2px
    classDef level2 color:#000,fill:#e0a458,stroke:#333,stroke-width:1px
    classDef level3 color:#000,fill:#419d78,stroke:#333,stroke-width:1px
    classDef level4 color:#000,fill:#c04abc,stroke:#333,stroke-width:1px
    classDef level5 color:#000,fill:#f1c40f,stroke:#333,stroke-width:1px
    classDef level6 color:#000,fill:#f1c40f,stroke:#333,stroke-width:1px
    classDef highlight color:#000,fill:#fff,stroke:#000,stroke-width:5px



  %% Apply classes
  class A level2
class B level4
class C level6
class D level6
class E level6
class F level6
class G level6
class H level6
class I level6
class J level6
class K level6
class L level6
class M level6
class N level6
class O level6
class P level6
class Q level6
class R level6
class S level6
class T level6
class U level6
class V level6
class W level6
class X level6
class Y level6

  class C highlight

  %% class A level1
  %% class B,C level2
  %% class D,E,F,G,H,I level2
  %% class J,K,L,M,N,O,P level3
  %% class C highlight